Food and Drugs Administration

Gastrointenstinal Drugs Advisory Committee

June 26, 2003

Slides

Photofrin®

Disclaimer

The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

Introduction, Dr. Francois Martin, MD, Axcan Pharma, Inc. (HTM) (PPT)

Photofrin® PDT for High-Grade Dysplasia in Barrett's Esophagus, Dr. Edvardas Kaminskas, MD, & Dr. Milton Fan, PhD, FDA (HTM) (PPT)